By the bestofme Editorial Team — evidence-based research based on peer-reviewed dermatology literature (PubMed/NCBI). Medical disclaimer: this article does not replace professional dermatological advice.
Exploring the potential therapeutic significance of secukinumab for annular epidermolytic ichthyosis. (PMID: 43042448) — relevance score 83/100.
Annular epidermolytic ichthyosis (AEI), also known as KRT1/KRT10-nEDD-annular, is a rare autosomal dominant disorder characterized by recurrent annular erythema on the trunk and proximal extremities. Currently, the treatment of AEI is limited to the use of emollients, keratolytics, and oral retinoid [...]
The data adds to a growing body of evidence on Retinoid. When evaluating claims, remember: EU cosmetic regulation (EC 1223/2009) requires substantiated efficacy claims, and meaningful endpoints are barrier function, hydration, and measurable skin parameters.
Recommended categories: Retinoid serum, moisturizer with Retinoid, Retinoid cleanser — see our tests for current picks.
When will I see results? Typically after 4–12 weeks of consistent use, depending on skin condition and concentration.
Who is it for? Most skin types — sensitive skin (rosacea, eczema) should introduce slowly and consult a dermatologist.
Any risks? Low when used correctly. Mild initial irritation ("purging") is common and should subside.
Anzeige 1
Neue Retinoid-Forschung (PMID 42828677) evidenzbasiert eingeordnet: Was die Daten für deine Routine bedeuten — mit Praxis-Guide und FAQ.
Die perfekte Abendroutine Hautpflege für die Nacht: Double Cleansing, Retinol, Nachtpflege. Wissenschaftlich erklärt mit Produktempfehlungen für jeden Hauttyp.
Neue Bakuchiol-Forschung (PMID 42242599) evidenzbasiert eingeordnet: Was die Daten für deine Routine bedeuten — mit Praxis-Guide und FAQ.
Our analyses are fact-based. Discover what's really in your products.